Last reviewed: June 16, 2026
Last updated: June 16, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Glucagon-like peptide-1 (GLP-1) medications have transformed weight loss treatment by targeting the brain circuits that control appetite and blood sugar regulation. Clinical trials show that patients using GLP-1 therapy lose an average of 15-22% of body weight over one year. PlexusDx specializes in precision GLP-1 therapy, offering multiple delivery methods and personalized options from licensed 503A compounding pharmacies across all 50 states.
How GLP-1 Medications Work for Weight Loss
GLP-1 receptor agonists function by mimicking a natural hormone your intestines produce after eating. When this medication binds to GLP-1 receptors in your brain, it slows gastric emptying, reduces hunger signals, and increases feelings of fullness from smaller meal portions. This mechanism allows your body to naturally consume fewer calories without the constant battle against cravings.
Beyond appetite suppression, GLP-1 medications improve blood sugar control and enhance insulin secretion in response to meals. These dual actions create a metabolic environment where your body becomes more efficient at processing glucose and storing less energy as fat. Studies demonstrate that GLP-1 therapy produces sustainable results because it addresses hunger at its neurological source rather than relying on willpower alone.
Semaglutide vs. Other GLP-1 Options: Understanding Your Choices
Semaglutide and tirzepatide represent two of the most extensively researched GLP-1 medications available today. Semaglutide activates GLP-1 receptors exclusively, while tirzepatide activates both GLP-1 and GIP receptors, potentially offering enhanced weight loss for certain individuals. PlexusDx offers compounded semaglutide injection starting at $149 per month, oral semaglutide at $249 monthly, and tirzepatide options for those seeking dual-pathway activation.
Choosing between these medications depends on your metabolic profile, tolerance for injection therapy, and individual response patterns. Some patients achieve their goals with semaglutide alone, while others benefit from tirzepatide's additional GIP pathway engagement. PlexusDx can guide this selection process, and the Precision Peptide Genetic Test helps identify which peptide pathways your genetics favor most strongly.
Genetic Testing: Personalizing Your GLP-1 Treatment Path
Not every patient responds identically to the same GLP-1 medication, and genetic variations explain much of this difference. PlexusDx offers the Precision Peptide Genetic Test, which analyzes 14 metabolic pathways and 150+ genetic insights to identify your individual response potential. Key variants like GLP1R rs6923761, GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 directly influence how effectively your body responds to GLP-1 therapy.
This test costs just $99 as an add-on after your first month of treatment, providing data that informs whether semaglutide, tirzepatide, or a dual-compound approach suits your genetic predispositions best. Rather than relying on trial-and-error, genetic insights allow PlexusDx clinicians to recommend the medication most likely to produce optimal weight loss for your unique biology. This precision approach maximizes your chances of success while minimizing unnecessary treatment adjustments.
Pricing, Access, and Support: PlexusDx Makes GLP-1 Affordable
PlexusDx breaks down barriers to GLP-1 access by offering treatment without requiring insurance, membership fees, or long-term contracts. Compounded semaglutide injection begins at $149 per month across three commitment tiers, with a clear promise: your dose may need to go up, but your price won't. This pricing structure ensures that dose escalation never surprises you with unexpected costs, removing financial anxiety from your treatment journey.
All medications come from licensed 503A compounding pharmacies regulated for safety and quality, serving patients in all 50 states. PlexusDx accepts HSA and FSA payments, providing additional savings opportunities for those with health accounts. Whether you prefer injection therapy, oral medications, or the innovative GLP-Squared dual-compound options, flat monthly pricing allows you to focus entirely on your health goals rather than cost concerns.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Which GLP-1 medication produces the most weight loss?
Tirzepatide generally shows slightly higher average weight loss (20-22%) compared to semaglutide (15-18%) in head-to-head trials, but individual results vary significantly based on genetics and lifestyle. PlexusDx recommends the Precision Peptide Genetic Test to identify whether your genetic profile favors GLP-1 single-pathway activation or dual-pathway tirzepatide therapy for maximum personal results.
Is compounded semaglutide as effective as brand-name Ozempic?
Compounded semaglutide from licensed 503A pharmacies contains the identical active ingredient as brand-name versions and delivers equivalent clinical results. PlexusDx sources from regulated compounding facilities that meet rigorous quality standards, ensuring bioavailability and efficacy while reducing your monthly cost to $149 versus $900+ for brand-name alternatives.
How quickly will I see weight loss results from GLP-1 therapy?
Most patients notice reduced appetite within 3-7 days of starting GLP-1 treatment, with measurable weight loss appearing within 2-4 weeks. Significant results typically emerge over 3-6 months as your body adapts and your dose reaches optimal levels. PlexusDx supports gradual dose increases that maximize both safety and effectiveness throughout your treatment.
What side effects should I expect from GLP-1 medications?
Common side effects include mild nausea, constipation, or reduced appetite for favorite foods—most resolve within 1-2 weeks as your body adjusts. Serious adverse events are rare with proper dosing and medical oversight, though GLP-1 therapy isn't suitable for those with personal or family history of thyroid cancer or multiple endocrine neoplasia. PlexusDx clinicians screen for contraindications and monitor your response throughout treatment.
Can the Precision Peptide Genetic Test predict which GLP-1 will work best for me?
Yes. The test analyzes variants in GLP1R, GIPR, FTO, and MC4R genes that directly influence your metabolic pathways and GLP-1 sensitivity. This data helps PlexusDx clinicians predict whether semaglutide, tirzepatide, or dual-compound therapy aligns with your genetic predispositions, increasing the probability of achieving your weight loss goals efficiently.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Can We Use Ozempic for Weight Loss? Exploring Its Role and Implications
Can Type 1 Diabetics Take Ozempic? Navigating New Frontiers in Diabetes Management